| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 8e-07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.069 | 0.2 |